Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What began as a one-person operation has grown into a team of more than 25 people, but one thing has remained constant - our mission
By Drug Class : Dulaglutide Liraglutide Semaglutide Lixisenatide Exenatide Tirzepatide The GLP-1 receptor agonist market from the dulaglutide is anticipated to grow at a robust pace over 2023-2032 attributed to its rising utilisation by healthcare professionals due to its efficacy in glycemic control, weight management, and cardiovascular benefits
Studies, like the STEP 5 trial, show that people on semaglutide continue losing weight gradually, with an average weight loss of 15% of their body weight after two years (104 weeks)
Unfortunately, the oral GLP-1 medications are priced at the same high price as the injections.
Total scale weight change typically ranges from 25-40 pounds with simultaneous muscle gain partially offsetting fat loss
Patients with a high body mass index (BMI) often find that semaglutide, combined with regular physical activity , provides effective results in their weight loss journey
US$ 24.32
US$ 27.82
US$ 24.74
